AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

ADC Therapeutics S.A.

$1.53 -$1.99 (-56.53%)
NYSE · 30 Oct 2026 20:00 UTC
Previous Close
$1.49
Day Range
$1.43$1.54
Year Range
$0.78$4.98
Market Cap
195.33M
AVG Volume
1.46M
Trailing/Forward PE
-2.31/-
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
2026-11-10
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ADCT Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q278.77M
26 Q178.36M
25 Q481.36M
25 Q375.21M
25 Q277.25M
25 Q175.82M
24 Q470.84M
24 Q370.72M
24 Q266.75M
24 Q168.62M
Net Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ADCT Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-96.91M
26 Q1-136.99M
25 Q4-142.62M
25 Q3-166.94M
25 Q2-169.94M
25 Q1-149.84M
24 Q4-157.85M
24 Q3-212.15M
24 Q2-215.99M
24 Q1-228.37M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ADCT Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-99.11M
26 Q1-117.84M
25 Q4-121.06M
25 Q3-135.37M
25 Q2-140.61M
25 Q1-125.5M
24 Q4-130.65M
24 Q3-138.2M
24 Q2-140.04M
24 Q1-150.64M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ADCT

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 10 Nov 2026.

ADC Therapeutics S.A.
ADCT
Stockpicker

Video analysis: ADCT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ADCT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.